GSK Egypt obtains shareholders’ nod for 2023 cash dividends

Non-consolidated net profits plunged year-on-yearto $1.54mlnin 2023

Staff Writer, Mubasher

April 30, 2024

PHOTO

Cairo – GlaxoSmithKline (GSK Egypt) plans to disburse cash dividends valued at EGP 0.75 per share for 2023, according to a bourse filing.

The board members greenlighted the cash dividends last March, while the shareholders granted their approval during the ordinary general meeting (OGM) held on 28 April 2024.

Last year, the EGX-listed firm posted a consolidated net profit amounting to EGP 60.47 million, down from EGP 735.39 million as of 31 December 2022.

Non-consolidated net profits plunged year-on-year (YoY) to EGP 74.09 million in 2023 from EGP 718.18 million.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.